フロリダ州における濾胞性リンパ腫の臨床試験
フロリダ州内の拠点で、濾胞性リンパ腫に関する25件の研究が参加者を募集しています。
フロリダ州内の都市
公式研究テキスト（英語）
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
- UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
- UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- 他6件
被験者募集中第3相
12歳以上 · 全性別 · 2026/10/02更新 · NCT07215910A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Mayo Clinic Jacksonville, Jacksonville
- Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
- Tampa General Hospital Cancer Institute, Tampa
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT05006716Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
- Moffitt Cancer Center, Tampa
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06350318A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- University of Miami - Sylvester Cancer Center, Miami
- Florida Cancer Specialists - Sarasota, Sarasota
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07226843A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Research Site, Jacksonville
被験者募集中第3相
18歳〜130歳 · 全性別 · 2026/09/21更新 · NCT06549595Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Research Site, Tampa
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06526793Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Mayo Clinic Jacksonville, Jacksonville
- AdventHealth, Orlando
被験者募集中第3相
12歳〜100歳 · 全性別 · 2026/09/11更新 · NCT06784752Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
- UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- 他6件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06860594A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
- Research Site, Miami Lakes
被験者募集中第1相健康なボランティア歓迎
18歳〜85歳 · 全性別 · 2026/09/01更新 · NCT07546760SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Florida Health, Gainesville
- Mayo Clinic - Florida, Jacksonville
- University of Miami Health, Miami
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT05303519A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
- Boca Raton Clinical Research (BRCR) Global, Plantation
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/14更新 · NCT06149286Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
- Gateway Community Services, Jacksonville
- IBIS Behavioral Health, Tampa
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT06651177Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- Mayo Clinic, Clinical Trials Referral Office, Jacksonville
被験者募集中第1/2相
13歳〜90歳 · 全性別 · 2026/08/06更新 · NCT06533579A Study of APG-3288 in Relapsed/Refractory Blood Cancers
- Mayo Clinic, Jacksonville
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/30更新 · NCT07424833A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- University of Miami, Miami
- Florida Cancer Specialists, Sarasota
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/02更新 · NCT05131022A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
- UF Health, Gainesville
被験者募集中第1相
4歳以上 · 全性別 · 2026/06/25更新 · NCT04573140A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
- Orlando Clinical Research Center, Orlando
被験者募集中第1相
18歳〜80歳 · 全性別 · 2026/06/16更新 · NCT07559474A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
- Local Institution - 0008, Jacksonville
- Local Institution - 0214, Tampa
- Local Institution - 0217, Tampa
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/20更新 · NCT06911502The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- ASCLEPES Research Centers, Weeki Wachee
被験者募集中第1/2相
12歳〜95歳 · 全性別 · 2026/04/15更新 · NCT04329728Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma
- Florida Cancer Specialists and Research Institute, Fort Myers
- University of Miami, Miami
被験者募集中第2相
18歳以上 · 全性別 · 2026/03/23更新 · NCT04998669Study of SGR-1505 in Mature B-Cell Neoplasms
- Napa Research, Pompano Beach
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/13更新 · NCT05544019B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies
- Mayo Clinic in Florida, Jacksonville
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/13更新 · NCT06191887AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
- Mount Sinai Comprehensive Cancer Center, Miami Beach
- Moffitt Cancer Center, Tampa
被験者募集中第1相
18歳以上 · 全性別 · 2025/12/10更新 · NCT05602363SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Jacksonville
- Massive Bio SYNERGY-AI site, Miami
- Massive Bio SYNERGY-AI site, Tampa
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
- Florida Cancer Specialists, Sarasota
被験者募集中第1相
18歳以上 · 全性別 · 2025/10/02更新 · NCT05780034ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。